×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| WANBURY LTD. | 1635.32 | 134.91 | 1631.84 | 3.95 | 875.0 | 20.3 |
| Sastasundar Ventures Limited | 3.54 | -1.09 | 0.97 | -0.03 | 863 | 24.0 |
| ANUH PHARMA LTD. | 1898.68 | 83.01 | 1864.79 | 1.66 | 857 | 18.6 |
Wanbury Limited, with Security Code 524212, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 133.0 | 146.3 | 144.5 | 145.5 | 139.4 | 131.1 | 161.2 | 133.5 | 172.0 | 163.2 |
| Expenses | 118.8 | 132.9 | 127.1 | 124.4 | 121.2 | 120.1 | 141.2 | 119.5 | 142.3 | 138.7 |
| Operating Profit | 14.2 | 13.3 | 17.3 | 21.1 | 18.2 | 11.0 | 20.0 | 13.9 | 29.7 | 24.4 |
| OPM % | 10.65% | 9.12% | 12.01% | 14.53% | 13.03% | 8.37% | 12.41% | 10.45% | 17.28% | 14.98% |
| Other Income | -2.7 | 0.6 | 0.8 | 0.7 | 0.9 | 0.9 | 1.6 | 0.8 | 1.8 | 0.3 |
| Interest | 7.5 | 5.8 | 7.7 | 8.3 | 7.5 | 7.6 | 10.1 | 10.2 | 9.0 | 7.5 |
| Depreciation | 3.1 | 3.2 | 3.2 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.4 | 3.6 |
| Profit before tax | 1.5 | 5.0 | 7.2 | 10.3 | 8.3 | 1.0 | 8.2 | 1.3 | 19.1 | 13.6 |
| Tax % | 10.3% | -6.1% | 2.4% | 0.2% | -3.3% | 0% | -1.8% | 5.7% | 6.3% | 0.8% |
| Net Profit | 1.0 | 4.7 | 7.4 | 10.3 | 8.1 | 1.0 | 8.0 | 1.2 | 20.3 | 13.5 |
| EPS in Rs | 0.8 | 1.43 | 2.25 | 3.14 | 2.37 | 0.31 | 2.44 | 0.7 | 0 | 3.95 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 125.8 | 133.0 | 146.3 | 144.5 | 145.5 | 139.4 | 131.1 | 161.2 | 133.5 | 172.0 |
| Expenses | 119.3 | 118.8 | 132.9 | 127.1 | 124.4 | 121.2 | 120.1 | 141.2 | 119.5 | 142.3 |
| Operating Profit | 6.5 | 14.2 | 13.3 | 17.3 | 21.1 | 18.2 | 11.0 | 20.0 | 13.9 | 29.7 |
| OPM % | 5.13% | 10.65% | 9.12% | 12.01% | 14.53% | 13.03% | 8.37% | 12.41% | 10.45% | 17.28% |
| Other Income | 0.3 | -2.7 | 0.6 | 0.8 | 0.7 | 0.9 | 0.9 | 1.6 | 0.8 | 1.8 |
| Interest | 6.6 | 7.5 | 5.8 | 7.7 | 8.3 | 7.5 | 7.6 | 10.1 | 10.2 | 9.0 |
| Depreciation | 3.1 | 3.1 | 3.2 | 3.2 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.4 |
| Profit before tax | -3.0 | 1.5 | 5.0 | 7.2 | 10.3 | 8.3 | 1.0 | 8.2 | 1.3 | 19.1 |
| Tax % | 7.6% | 10.3% | -6.1% | 2.4% | 0.2% | 0.8% | 0% | 1.8% | -5.7% | 6.3% |
| Net Profit | -3.3 | 1.0 | 4.7 | 7.4 | 10.3 | 33.6 | 1.0 | 8.0 | 1.2 | 20.3 |
| EPS in Rs | -1 | 0.8 | 1.43 | 2.25 | 3.13 | 12.45 | 0.31 | 2.34 | 0.7 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 30% |
| 3 Years: | 78% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 74% |
| 3 Years: | 62% |
| 1 Year: | 95% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 30% |
| 3 Years: | 75% |
| TTM: | -8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 74% |
| 3 Years: | 62% |
| 1 Year: | 95% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|